Fingerprint
Dive into the research topics of '6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically